Viridian Therapeutics logo
Healthcare & Life Sciences

Viridian Therapeutics

Viridian Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.

Activeseries-b
series-b
Stage
1
Investors

About Viridian Therapeutics

Viridian Therapeutics is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Viridian Therapeutics develops antibody-based therapies targeting rare autoimmune diseases, with programs focused on Thyroid Eye Disease and FcRn pathways.

Explore Viridian Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States